|
99
|
234
|
7o5fA |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-161 |
|
99
|
234
|
7o5sA |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-167 |
|
100
|
235
|
7nr7A |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-111 |
|
98
|
235
|
7nleA |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-118 |
|
97
|
235
|
7nrkA |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1002f1 |
|
99
|
235
|
7nj6A |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1005 |
|
100
|
235
|
7nixA |
14-3-3 sigma with as160 binding site pt642 |
|
101
|
234
|
7nj8A |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1007 |
|
97
|
235
|
7nifA |
14-3-3 sigma with pin1 binding site ps72 and covalently bound tcf521-011 |
|
97
|
234
|
7nm3A |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-135 |
|
101
|
235
|
7bg3A |
14-3-3 sigma with pin1 binding site ps72 and covalently bound pc2046 |
|
100
|
235
|
7bdpA |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1017 |
|
0
|
7
|
7az1P |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1013 |
|
98
|
234
|
7nm1A |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-126 |
|
0
|
9
|
7bgvP |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1012 |
|
99
|
236
|
7axnA |
14-3-3 sigma in complex with pin1 binding site ps72 and covalently bound tcf521-026 |
|
0
|
9
|
7axnP |
14-3-3 sigma in complex with pin1 binding site ps72 and covalently bound tcf521-026 |
|
100
|
234
|
7o5uA |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-168 |
|
99
|
236
|
7aogA |
14-3-3 sigma in complex with pin1 binding site ps72 |
|
99
|
235
|
7az1A |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1013 |
|
0
|
7
|
7ayfP |
14-3-3 sigma with pin1 binding site ps72 and covalently bound tcf521-110 |
|
0
|
7
|
7az2P |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1014 |
|
98
|
235
|
7ayfA |
14-3-3 sigma with pin1 binding site ps72 and covalently bound tcf521-110 |
|
0
|
8
|
7bdyP |
14-3-3 sigma with pin1 binding site ps72 and covalently bound pc2068b |
|
98
|
235
|
7bgrA |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1016 |
|
97
|
236
|
7bgvA |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1012 |
|
100
|
235
|
7az2A |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1014 |
|
97
|
235
|
7bgwA |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1011 |
|
99
|
235
|
7bi3A |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-179 |
|
98
|
235
|
7biqA |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-180 |
|
100
|
236
|
7biyA |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-175 |
|
99
|
235
|
7bjwA |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-154 |
|
102
|
235
|
7bdtA |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1009 |
|
98
|
234
|
7bkhA |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-153 |
|
103
|
236
|
7bfwA |
14-3-3 sigma with pin1 binding site ps72 and covalently bound pc2068a |
|
104
|
236
|
7bdyA |
14-3-3 sigma with pin1 binding site ps72 and covalently bound pc2068b |
|
99
|
236
|
7bjlA |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-142 |
|
99
|
236
|
7bjfA |
14-3-3 sigma with rela/p65 binding site ps45 and covalently bound tcf521-069 |
|
98
|
235
|
7bgqA |
14-3-3 sigma with pin1 binding site ps72 and covalently bound lvd1019 |
|
102
|
236
|
6yiaA |
14-3-3 sigma in complex with smad2 ps465 peptide |
|
103
|
236
|
6yicA |
14-3-3 sigma in complex with smad4 ps403 peptide |
|
99
|
236
|
6yibA |
14-3-3 sigma in complex with smad3 ps423 peptide |
|
100
|
236
|
6ye9A |
Small-molecule inhibitor of 14-3-3 protein-protein interactions |
|
99
|
236
|
6y7tA |
Engineered conjugation of lysine-specific molecular tweezers with exos derived peptidic inhibitor enhance affinity towards target protein 14-3-3 through ditopic binding |
|
1
|
10
|
6y7tD |
Engineered conjugation of lysine-specific molecular tweezers with exos derived peptidic inhibitor enhance affinity towards target protein 14-3-3 through ditopic binding |
|
103
|
236
|
7nfwA |
Human 14-3-3 sigma in complex with human estrogen receptor alpha peptide |
|
0
|
8
|
6xwdP |
14-3-3 sigma bound to canonical mono-phosphorylated aminopeptidase n (apn, cd13) binding motif |
|
101
|
236
|
6xwdA |
14-3-3 sigma bound to canonical mono-phosphorylated aminopeptidase n (apn, cd13) binding motif |
|
100
|
236
|
6yluA |
14-3-3sigma in complex with blnkpt152 phosphopeptide crystal structure |
|
98
|
236
|
6y58A |
Binary complex of 14-3-3 sigma (c38n) with the estrogen related receptor gamma (lbd) phosphopeptide |
